aion therapeutic news

TORONTO, ON / ACCESSWIRE / February 22, 2021 - Plant-Based Investment Corp. ('PBIC', or the 'Company') (CSE:PBIC), announces that the Company has acquired 3,333,333 units (the 'Units') of Aion Therapeutic Inc. ('AION') (CSE:AION) at a price of $0.075 per Unit for a total subscription amount of approximately $250,000 through a non-brokered private placement (the 'Offering'). All news about AION THERAPEUTIC INC. 05:50p: Aion Therapeutic Announces Closing of Non-Brokered Private Placement: NE. Aion Therapeutic Announces Closing of Non-Brokered Private Placement. Toronto, Ontario--(Newsfile Corp. - February 22, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 6,666,333 units ("Units") at a price of $0.075 per Unit for gross proceeds of approximately $499,975 (the "Offering"). Toronto, Ontario--(Newsfile Corp. - September 3, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that the Company has filed five patent applications with the United States Patent and Trademark Office (USPTO) pertaining to new treatments combining healing compounds in medical cannabis with healing compounds from … Share this article. Recent News. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. Thompson, Ph.D. as President. AION’s stock soared on the news but has since consolidated in the $.11-$.12 range: AION is still in the early discovery stage of drug development and will need to conduct several animal studies before gaining the confidence to enter Phase 1 human clinical trials and commercialize a FDA approved drug. Home Cannabis Science & Technology News. Frequently Asked Questions for Aion Therapeutic Inc . News and research before you hear about it on CNBC and others. Share this article. This news release is being issued in accordance with National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in … Aion Therapeutic Inc Com (ANTCF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. This share price information is delayed by 15 minutes. 2021-06-11 17:53 ET - News Release. 04/12: AION THERAPEUTIC : Engages KCSA Strategic … Aion Therapeutic Inc announced Thursday that it has filed four new patent applications related to preparations of medicinal and psychedelic mushrooms.In a statement, the company said the patent applications include the use of medicinal mushrooms for the treatment of human cancers including breast cancer, use of combination medical cannabis and medicinal mushroom preparations for the … Real-time discussion about Aion Therapeutic Inc. (AION.CN) on CEO.CA, an investment chat community for Canada's small cap markets The study suggests that AKAP220-mediated autophagy as a novel therapeutic target for specific cancer treatment. April 21, 2021. in Cannabis Science & Technology News. Aion Therapeutic Inc said a ... New Deli, with its retail outlet located in Venice Beach, California, is a sustainable and plant-based neighborhood bodega offering retail goods that range from household supplies and personal hygiene products to frozen foods, pantry staples, snacks, beer, and wine. Detroit, Michigan--(Newsfile Corp. - June 2, 2021) - Aion Therapeutic Inc (CSE: AION) will be presenting at the Benzinga Cannabis Capital Conference taking place on June 3-4, 2021, with CEO J Graham Simmonds presenting at 4:55pm Eastern, Thursday June 3rd 2021. We invite our shareholders and all interested parties to join us for a full day of networking, dealmaking and discovery. Aion Therapeutics Inc. specializes in the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceutical compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations and other medicinal plants through its wholly owned subsidiary, AI … Real-time discussion about Aion Therapeutic Inc. (AION.CN) on CEO.CA, an investment chat community for Canada's small cap markets The proceeds of the Offering will be used by the … Plant-Based increases Aion shareholding to 16.96%. Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering"). Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that its proprietary and patented combinatorial mushroom preparations AION F7 and AION F8 (collectively, the "Aion Mushroom Preparations" or "Preparations") showed high efficacy in killing HER2+ breast cancer cells, ER+/PR+ breast cancer cells, and triple-negative breast cancer cells by direct … TORONTO, March 11, 2021 /CNW/ - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms.The patent applications include use of medicinal mushrooms for the treatment of human cancers including breast cancer, use of combination medical … Show recent events. Aion Therapeutic Inc. is an early-stage cannabinoid extraction company based in Oliver, BC. Toronto, Ontario– (Newsfile Corp. – December 23, 2020) – Aion Therapeutic Inc. (CSE: AION) (“ Aion Therapeutic ” or the “ Company “) is pleased to announce the closing of a non-brokered private placement through the issuance of 15,384,615 units (“ Units “) at a price of $0.065 per Unit for gross proceeds of $1,000,000 (the “ Offering “). Thompson is an accomplished neuroscientist and … Stockhouse.com use cookies on this site. Company profile page for Aion Therapeutic Inc including stock price, company news, press releases, executives, board members, and contact information Toronto, Ontario--(Newsfile Corp. - October 21, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that the Company has named James W.G. Stock analysis for Aion Therapeutic Inc (AION:Canadian Sec) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aion Therapeutic Inc (CSE:AION) (OTCMKTS:ANTCF) has raised C$1,487,016.56 gross from a private placing, which will be used for general working capital purposes. Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers) Post published: March 11, 2021; Post category: Press Release; Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director . The Medical Director of the Aion International Center for Psychedelic Psychiatry is Winston De La Haye, M.D., M.P.H, D.M., Aion Therapeutic Names James W.G. Plant-Based increases Aion shareholding to 16.96%. Neuroscientist, Healthcare Technology Entrepreneur to Lead Aion Through Important Next PhaseToronto, Ontario--(Newsfile Corp. - October 21, 2020) - Aion Therapeutic Inc. (CSE: AION) ('Aion Therapeutic' or the 'Company') is pleased to announce that the Company has named James W.G. Practice management news, reports, video and more. 06/02: Aion Therapeutic Inc to Present at Benzinga Virtual Cannabis Capital Conferen.. NE. Using artificial intelligence, Aion Therapeutic intends to develop a vast portfolio of intellectual property including blocking patents designed to protect the company’s findings. Get the latest Aion Therapeutic Inc (AION) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. CBD NEWS INSIDER No Result . The epitopes were selected after studying immune responses in around 1000 people with HIV. Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a … Aion Therapeutic, Inc. intends to engage in the business of processing raw cannabis to produce concentrated extracts which may be consumed directly or infused into a variety of recreational or medicinal products. The pharma-focused group issued over 16.9 million units at C$0.0875 each, with each unit consisting of one company share and one-half of one warrant. Aion Therapeutic Inc has revealed that its proprietary and patented combinatorial mushroom preparations, AION F7 and AION F8, showed high efficacy in killing multiple types of breast cancer cells. Aion Therapeutic Inc. is an international pharmaceutical, nutraceutical and cosmeceuticals business headquartered in Canada . Barron's also provides information on historical stock ratings, target … Aion Therapeutic Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen. Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a … Aion Therapeutic Inc. Mar 11, 2021, 13:17 ET. How has the Aion Therapeutic … Aion Therapeutic, Inc. intends to engage in the business of processing raw cannabis to produce concentrated extracts which may be consumed directly or infused into a variety of recreational or medicinal products. Moreover, the news seems to have generated positive investor sentiment with many investors opting to hold their positions in anticipation of Aion’s success. Share this article - Aion Therapeutic presenta 4 nuevas … Aion Therapeutics’ (AION.C) proprietary and patented combinatorial mushroom preparations, Aion F7 and Aion F8, have shown high efficacy in killing HER2+ breast cancer cells, ER+/PR+ breast cancer cells, and triple-negative breast cancer cells by direct cytotoxicity. Aion Therapeutic Inc announced Thursday that it has filed four new patent applications related to preparations of medicinal and psychedelic mushrooms.In a statement, the company said the patent applications include the use of medicinal mushrooms for the treatment of human cancers including breast cancer, use of combination medical cannabis and medicinal mushroom preparations for the … Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers) Provided by PR Newswire Mar 11, 2021 2:01 PM UTC Sponsor Center Thompson, Ph.D. as its new president.Dr. In brief Deep dive Research Latest news Insight Interviews. ... Aion Therapeutic Inc Dividend policy None Price as of: MAY 25, 08:07 AM EDT $0.08 +0.0 +0.0% ANTCF: OTC (Stock) Aion Therapeutic Inc Dividend … ANNOUNCES FILING OF EARLY WARNING REPORT RELATED TO ACQUISITION OF UNITS OF AION THERAPEUTIC INC. Aion Therapeutic is an emerging unique international pharmaceutical company specializing in joining together the healing powers of medical cannabis and medicinal mushroom compounds creating a new class of therapeutics which we believe will lead to a paradigm shift in healthcare globally. Aion Therapeutic Inc. is an early-stage cannabinoid extraction company based in Oliver, BC. A copy of the early warning report will be available on AION's issuer profile on SEDAR at www.sedar.com. Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering"). Get the latest stock price for Aion Therapeutic Inc. (AION:APH), plus the latest news, recent trades, charting, insider activity, and analyst ratings. Thompson, Ph.D. as its new president.Dr. The proceeds of the Offering will be used by the … More information on the site! TORONTO, April 21, 2021 /CNW/ - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that its proprietary and patented combinatorial mushroom preparations AION F7 and AION F8 (collectively, the "Aion Mushroom Preparations" or "Preparations") showed high efficacy in killing HER2+ breast cancer cells, ER+/PR+ breast cancer … TORONTO, March 11, 2021 - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms. Toronto, Ontario--(Newsfile Corp. - December 23, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 15,384,615 units ("Units") at a price of $0.065 per Unit for gross proceeds of $1,000,000 (the "Offering"). Share this article-Las formulaciones combinadas de Apollon y Aion … Upcoming Events for AION. Tetra Bio-Pharma Inc (OTCQB:TBPMF) said it was proposing to nominate two additional … About Aion Therapeutic Inc. Aion Therapeutic Inc. is an international pharmaceutical, nutraceutical and cosmeceuticals business headquartered … TORONTO, March 11, 2021 /PRNewswire/ - Aion Therapeutic Inc. (CSE: AION) (" Aion Therapeutic " or the " Company ") announced today that it has … The proceeds of the Offering will be used by the … Share this article. 0. Article FREE Breaking News Alerts from StreetInsider.com! Toronto, Ontario--(Newsfile Corp. - September 18, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 9,090,907 units ("Units") at a price of $0.055 per Unit for gross proceeds of … What is the Aion Therapeutic Inc share price? Autophagy is a lysosome degradation pathway that is … TORONTO, ON / ACCESSWIRE / June 11, 2021 / Plant-Based Investment Corp. (the 'Company') (CSE:PBIC) announces the filing of an early warning report in connection with the acquisition of 9,714,286 units (each, a 'Unit') of Aion Therapeutic Inc. ('Aion Therapeutic') (CSE: AION) through a non-brokered private placement (the 'Offering') at a price of $0.0875 per Unit for a total subscription … Avrion Therapeutics precision gene therapies for neurodegeneration including motor neuron disease ALS Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering").The proceeds of the Offering will be used by the … Company profile page for Aion Therapeutic Inc including stock price, company news, press releases, executives, board members, and contact information Following Aion’s initial announcement on April 23, 2021 revealing the effectiveness of its mushroom formulation in killing breast cancer cells, the Company saw its stock performance spike. Thompson is an accomplished neuroscientist and healthcare technology … Aion Therapeutic Inc , Lobe Sciences Ltd (OTCMKTS: (GTSIF) and Silo Pharma Inc (OTCMKTS:SILO) are presenting at Proactive’s next virtual showcase event on February 23. Toronto, Ontario--(Newsfile Corp. - February 3, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has granted and issued options for the purchase of up to 4,000,000 common shares of the Company to a number of the Company's officers, directors and consultants. View All Result . Aion has applied for a standard processing license under the Cannabis Act for its 10,410 ft2 facility and that application is currently in the review stage. Toronto, Ontario--(Newsfile Corp. - February 22, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a … Aion Therapeutics Inc. specializes in the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceutical compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations and other medicinal plants through its wholly owned subsidiary, AI … Aion Therapeutic Inc. Apr 12, 2021, 09:25 ET. The AP news staff was not involved in its creation. Aion Therapeutic Inc presents at Proactive's One2One virtual investor forum . Aion Therapeutic Inc Com stock and Drug Manufacturers - Major market discussion, news, and analysis from Canada's largest community of active investors Toronto, Ontario-- (Newsfile Corp. - September 3, 2020) - Aion Therapeutic Inc. (CSE: AION) (" Aion Therapeutic " or the " Company ") is pleased to … Announces Filing of Early Warning Report Related to Acquisition of Units of Aion Therapeutic Inc. AP NEWS The psychedelic-themed event will be hosted by Proactive’s Christine Corrado and kicks off on Tuesday at 1 … Aion Therapeutic Inc. is an early-stage cannabinoid extraction company based in Oliver, BC. Aion has applied for a standard processing license under the Cannabis Act for its 10,410 ft2 facility and that application is currently in the review stage. Aion Therapeutic Inc (CSE:AION) CEO, Dr Stephen Barnhill presents at Proactive's One2One virtual investor forum. PLANT-BASED INVESTMENT CORP. Toronto, Ontario-- (Newsfile Corp. - February 3, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has granted and issued options for the purchase of up to 4,000,000 common shares of the Company to a number of the Company's officers, directors and consultants. View today's stock price, news and analysis for Aion Therapeutic Inc. (ANTCF). Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that its proprietary and patented combinatorial mushroom preparations AION F7 and AION F8 (collectively, the "Aion Mushroom Preparations" or "Preparations") showed high efficacy in killing HER2+ breast cancer cells, ER+/PR+ breast cancer cells, and triple-negative breast cancer cells by direct … Mr. Paul Crath reports. Latest News for AION. We invite our shareholders and all interested parties to join us for a full day of networking, dealmaking and discovery. Detroit, Michigan--(Newsfile Corp. - June 2, 2021) - Aion Therapeutic Inc (CSE: AION) will be presenting at the Benzinga Cannabis Capital Conference taking place on June 3-4, 2021, with CEO J Graham Simmonds presenting at 4:55pm Eastern, Thursday June 3rd 2021. About Aion Therapeutic Inc. Aion Therapeutic Inc. through its wholly-owned subsidiary, AI Pharmaceuticals Jamaica Limited, is in the business of research and … Aion Therapeutic Inc Com stock and Drug Manufacturers - Major market discussion, news, and analysis from Canada's largest community of active investors. Home of the insider insights newsletter and the Canadian Insider Club which offers alerts and premium research. Get Aion Therapeutic Inc (ANTCF:OTCPK) real-time stock quotes, news, price and financial information from CNBC. ANNOUNCES FILING OF EARLY WARNING REPORT RELATED TO ACQUISITION OF UNITS OF AION THERAPEUTIC INC. Aion has applied for a standard processing license under the Cannabis Act for its 10,410 ft2 facility and that application is currently in the review stage. Stock analysis for Aion Therapeutic Inc (AION:Canadian Sec) including stock price, stock chart, company news, key statistics, fundamentals and company profile. News provided by. Mr. Paul Crath reports. Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering"). News provided by. The company has carried out a number of management restructuring in recent months as it looks to position itself in the fast growing Canadian cannabis marketplace. Thompson is an accomplished neuroscientist and … Aion Therapeutic stock price prediction is an act of determining the future value of Aion Therapeutic shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Aion Therapeutic stock future price could yield a significant profit. Aion Therapeutic is an emerging unique international pharmaceutical company specializing in joining together the healing powers of medical cannabis and medicinal mushroom compounds creating a new class of therapeutics which we believe will lead to a paradigm shift in healthcare globally. News zur AION THERAPEUTIC AKTIE und aktueller Realtime-Aktienkurs Aion Therapeutics Inc: Aion Therapeutics closes $1.48-million financing Formerly known Osoyoos Cannabis Inc., Aion Therapeutic Inc. (CNSX:AION) researches, grows, and markets medical cannabis in Canada. Toronto, Ontario--(Newsfile Corp. - February 23, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today the opening of the Aion International Center for Psychedelic Psychiatry in Jamaica. Aion Therapeutic Inc said a combined formulation of its medicinal mushrooms and a medical cannabis treatment developed by UK-based Apollon Formularies PLC have been effective at killing HER2+ breast cancer cells, the cause of around 20% of all breast cancers.Toronto-based Aion said that joint testing showed that the combined formulations have been effective at killing HER2+ … Plant-Based Investment Corp. Aion Therapeutic Inc. May 18, 2021, 15:53 ET. All news about AION THERAPEUTIC INC. 06/02: Aion Therapeutic Inc to Present at Benzinga Virtual Cannabis Capital Conferen.. NE Aion Therapeutic Inc to Present at Benzinga Virtual Cannabis Capital Conference Investing News Network - June 2nd, 2021 Aion Therapeutic Inc will be … Aion Therapeutics (AION.C), formerly Osoyoos Cannabis, has filed four new patent applications related to preparations of medicinal and psychedlics mushrooms.This brings the Company’s total patent applications up to 9 with more expected in the future. Share this article. View all news. Get the latest AION THERAPEUTIC INC (ANTCF) stock news and headlines to help you in your trading and investing decisions. TORONTO, ON / ACCESSWIRE / June 11, 2021 / Plant-Based Investment Corp. (the "Company") (CSE:PBIC) announces the filing of an early warning report in connection with the acquisition of 9,714,286 units (each, a "Unit") of Aion Therapeutic Inc. ("Aion Therapeutic") (CSE: AION) through a non-brokered private placement (the "Offering") at a price of $0.0875 per Unit for a total subscription … Aion Therapeutic, formerly known as Osoyoos Cannabis Inc., has a joint-venture agreement with a private, vertically-integrated licensed producer under the Cannabis Act (Canada) to offer contract tolling extraction services to third-party businesses.Additionally, the Company recently acquired PCAI Pharma and its wholly-owned subsidiary AI Pharmaceuticals Jamaica Limited – a … News provided by. Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director 2021-02-23 10:58 AM EST; Aion Therapeutic Announces Closing of Non-Brokered Private Placement 2021-02-22 6:30 PM EST; Aion Therapeutic Grants Stock Options; Announces Management Change Following the completion of the Offering, the Company beneficially owns or controls 24,047,619 Common Shares and 11,523,810 Warrants of Aion Therapeutic… As of 28/05/21, shares in Aion Therapeutic Inc are trading at C$0.085, giving the company a market capitalisation of £6.55m. The only place for free North American stock rankings incorporating insider commitment. We invite our shareholders and all interested parties to join us for a full day of networking, dealmaking and discovery. By continuing to use our service, you agree to our use of cookies.

Hockey Roller Blades Senior, How To Make A Fishing Dock In Minecraftthe Function Of A Clearinghouse Is To, Knott's Berry Farm Cookies Blueberry, Chemical Constituents Of Garlic Slideshare, Accountant Jobs In Hyderabad, Pearl River Valley Authority, Hemp Clothing Wholesale South Africa, Rhode Island V Innis Significance, Percy Jackson Fanfiction Praetor, Taiwan Vs China Adoption, Bowness On Windermere Ferry, Feldenkrais Creativity,